Your institution may have access to this item. Find your institution then sign in to continue.
Title
Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.
Authors
Nachega, Jean B; Hislop, Michael; Dowdy, David W; Chaisson, Richard E; Regensberg, Leon; Maartens, Gary
Abstract
Adherence of 95% or more to unboosted protease regimens is required for optimal virologic suppression in HIV-1-infected patients. Whether the same is true for nonnucleoside reverse transcriptase inhibitor (NNRTI)-based therapy is unclear.
Publication
Annals of internal medicine, 2007, Vol 146, Issue 8, p564